The factors such as increased radioisotopes applications, rise in public awareness, use of SPECT/CT and PET/CT imaging scans, abundance of radiopharmaceuticals, advancements in imaging technology (hybrid imaging), production of radiopharmaceuticals from cyclotrons are driving the market.
Nonalcholic Steatohepatitis (NASH) Also Known As “Fatty Liver” Causes Inflammation And Damages Liver By Accumulating Fat In People Who Do Not Abuse Alcohol, If Untreated This Leads To Cirrhosis. This Pipeline Analysis Gives Comprehensive Insights On Various Drugs Being Developed.
IQ4I Research & Consultancy published a new report on - Drug Discovery Outsourcing (DDO) Global Market - Forecast To 2027 analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 210 slide.
Small molecules continue to dominate the global therapeutics market, many molecules going off-patent is paving way for introduction of generics creating a favorable opportunity for the Pharmaceutical contract manufacturers.
This report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery, preclinical development, clinical phases and commercial manufacturing of biologics.
Contrast agents/Media are substances that improve the visibility of specific organs, tissues or blood vessels and help in diagnostic imaging and interventional procedures using medical imaging tools. The increase in diagnostic imaging procedures and interventional imaging procedures are driving the market growth.
Nuclear medicine is a highly multi-disciplined specialty sector where sophisticated instruments and radiopharmaceuticals are used. Advancements in radioactive tracers are enabling study of metabolic activities in different area of body.